Hun Mo Ryoo

1.4k total citations
47 papers, 930 citations indexed

About

Hun Mo Ryoo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Hun Mo Ryoo has authored 47 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 12 papers in Hematology. Recurrent topics in Hun Mo Ryoo's work include Gastric Cancer Management and Outcomes (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Treatments and Mutations (7 papers). Hun Mo Ryoo is often cited by papers focused on Gastric Cancer Management and Outcomes (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Treatments and Mutations (7 papers). Hun Mo Ryoo collaborates with scholars based in South Korea, United States and Nigeria. Hun Mo Ryoo's co-authors include Sung Hwa Bae, Myung Soo Hyun, Kyung Hee Lee, Hawk Kim, Min Kyoung Kim, Hong Song, Jung‐Hee Lee, Je‐Hwan Lee, Kyoo‐Hyung Lee and Young‐Don Joo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecular Therapy.

In The Last Decade

Hun Mo Ryoo

46 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hun Mo Ryoo South Korea	17	371	336	237	152	148	47	930
Po‐Min Chen Taiwan	17	461 1.2×	265 0.8×	359 1.5×	218 1.4×	104 0.7×	80	1.2k
Gabriele Buda Italy	17	352 0.9×	236 0.7×	389 1.6×	165 1.1×	71 0.5×	89	908
Elly Barry United States	12	310 0.8×	308 0.9×	157 0.7×	98 0.6×	174 1.2×	24	1.2k
Peter Kozuch United States	19	557 1.5×	176 0.5×	259 1.1×	135 0.9×	263 1.8×	42	1.1k
Andrew Eisenberger United States	17	288 0.8×	102 0.3×	333 1.4×	128 0.8×	165 1.1×	51	1.2k
Rosemary Young United Kingdom	10	695 1.9×	241 0.7×	226 1.0×	74 0.5×	199 1.3×	15	1.0k
Rob Pieters Netherlands	15	342 0.9×	266 0.8×	352 1.5×	46 0.3×	59 0.4×	27	957
Alexander Gural Israel	18	136 0.4×	313 0.9×	328 1.4×	68 0.4×	125 0.8×	48	885
Donna E. Levy United States	15	483 1.3×	232 0.7×	256 1.1×	114 0.8×	324 2.2×	24	1.5k
W ten Bokkel Huinink Netherlands	16	455 1.2×	65 0.2×	331 1.4×	119 0.8×	153 1.0×	23	1.2k

Countries citing papers authored by Hun Mo Ryoo

Since Specialization

Citations

This map shows the geographic impact of Hun Mo Ryoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hun Mo Ryoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hun Mo Ryoo more than expected).

Fields of papers citing papers by Hun Mo Ryoo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hun Mo Ryoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hun Mo Ryoo. The network helps show where Hun Mo Ryoo may publish in the future.

Co-authorship network of co-authors of Hun Mo Ryoo

This figure shows the co-authorship network connecting the top 25 collaborators of Hun Mo Ryoo. A scholar is included among the top collaborators of Hun Mo Ryoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hun Mo Ryoo. Hun Mo Ryoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kang, Jung Hun, Su‐Jin Koh, So Yeon Oh, et al.. (2020). Interference with daily functioning by breakthrough pain in patients with cancer. Supportive Care in Cancer. 28(11). 5177–5183. 11 indexed citations

Lee, In Hee, Byung Woog Kang, Jong Gwang Kim, et al.. (2018). Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy. The Korean Journal of Internal Medicine. 35(1). 185–193.

Kim, Jin Young, Young Rok, Hong Song, et al.. (2017). Multicenter Phase II Clinical Trial of Genexol-PM® with Gemcitabine in Advanced Biliary Tract Cancer. Anticancer Research. 37(3). 1467–1474. 23 indexed citations

Park, Sungwoo, Byung Woog Kang, Soo Jung Lee, et al.. (2017). Clinical significance of systemic chemotherapy after curative resection of metachronous pulmonary metastases from colorectal cancer. Cancer Chemotherapy and Pharmacology. 80(1). 187–193. 6 indexed citations

Park, In Hae, Joohyuk Sohn, Sung Bae Kim, et al.. (2016). An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer. Cancer Research and Treatment. 49(3). 569–577. 90 indexed citations

Oh, Sung Yong, Won Seog Kim, Jin Seok Kim, et al.. (2015). A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial. Leukemia & lymphoma. 57(6). 1406–1412. 4 indexed citations

Lee, A‐Jin, Ho Jun Lee, Jong-Dae Kim, et al.. (2014). Changes of Peripheral Blood Lymphocyte Subtypes in Patients with End Stage Cancer Administered Localized Radiotherapy and Bojungikki‐Tang. Evidence-based Complementary and Alternative Medicine. 2014(1). 207613–207613. 16 indexed citations

Baek, Sun Kyung, Hye Won Shin, Young Jin Choi, et al.. (2013). Noninterventional Observational Study Using High-Dose Controlled-Release Oxycodone (CR Oxycodone) for Cancer Pain Management in Outpatient Clinics. Pain Medicine. 14(12). 1866–1872. 3 indexed citations

Park, Silvia, Su Jin Lee, Kihyun Kım, et al.. (2013). Inclusion of hemoglobin level in prognostic score provides better prognostic stratification in patients with acute promyelocytic leukemia (APL). International Journal of Hematology. 97(3). 388–396. 5 indexed citations

10.

Lee, Je‐Hwan, Young‐Don Joo, Hawk Kim, et al.. (2012). Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine. Journal of Clinical Oncology. 31(6). 701–709. 77 indexed citations

11.

Kim, Hawk, Je‐Hwan Lee, Young‐Don Joo, et al.. (2012). A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome. Annals of Hematology. 91(9). 1459–1469. 18 indexed citations

12.

Kim, Min Kyoung, Cheolwon Suh, Hyun Sook, et al.. (2011). VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma. Cancer Science. 103(3). 497–503. 30 indexed citations

13.

Kim, Min Kyoung, Sung Hwa Bae, Young Kyung Bae, et al.. (2011). Biological Characterization of Nodal versus Extranodal Presentation of Diffuse Large B-Cell Lymphoma using Immunohistochemistry. Clinical Lymphoma Myeloma & Leukemia. 11(5). 403–408. 9 indexed citations

14.

Kim, Jong Gwang, Yee Soo Chae, Sang Kyun Sohn, et al.. (2009). Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin. Cancer Chemotherapy and Pharmacology. 64(5). 953–960. 21 indexed citations

15.

Kim, Hawk, Je‐Hwan Lee, Jung‐Hee Lee, et al.. (2008). Continuous infusion of intermediate‐dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: A prospective, multicenter phase II study. American Journal of Hematology. 84(3). 161–166. 7 indexed citations

16.

Kim, Jong Gwang, Sang Kyun Sohn, Hong Song, et al.. (2007). Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 60(6). 863–869. 15 indexed citations

17.

Bae, Sung Hwa, Hun Mo Ryoo, Young Rok, et al.. (2007). A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer. Lung Cancer. 59(1). 76–80. 3 indexed citations

18.

Kim, Bong-Seog, Soo‐Mee Bang, Jae Hoon Lee, et al.. (2005). The Clinical Efficacy of Helicobacter pylori Eradication in Patients with Helicobacter pylori-positive Chronic Thrombocytopenic Purpura. The Korean Journal of Hematology. 40(1). 23–23. 3 indexed citations

19.

Choi, Chul Won, Byung‐Soo Kim, Jae Hong Seo, et al.. (2001). Response to high‐dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients. American Journal of Hematology. 66(3). 197–202. 1 indexed citations

20.

Choi, Chul Won, Byung‐Soo Kim, Jae Hong Seo, et al.. (2001). Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients. American Journal of Hematology. 66(3). 197–202. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact